PLYMOUTH MEETING, PA — INOVIO (NASDAQ: INO) will present at two major investor conferences in December, setting the stage for fresh attention on the company’s DNA medicine pipeline as markets watch closely for new catalysts in cancer, HPV-related diseases, and infectious disease programs.
The biotechnology company will appear at the Piper Sandler 37th Annual Healthcare Conference in New York on Dec. 2, where executives will participate in a fireside chat from 8:30 to 8:55 a.m. ET. A live webcast and 90-day replay will be available at the link provided by the company.
INOVIO will return to New York on Dec. 11 for the Oppenheimer Movers in Rare Disease Summit, joining a panel featuring rapid-fire presentations from companies with near-term developments that could move markets. INOVIO is scheduled to present from 12:05 to 12:25 p.m. ET.
Company leaders will also participate in one-on-one meetings at both events, offering investors deeper insight into ongoing clinical programs and development priorities.
INOVIO develops and commercializes DNA medicines designed to stimulate the body to generate its own disease-fighting proteins. The company’s platform targets HPV-related conditions, cancers, and a range of infectious diseases.
Support the local news that supports Chester County. MyChesCo delivers reliable, fact-based reporting and essential community resources—free for everyone. If you value that, click here to become a patron today.